MEN — Molecular Energies Cashflow Statement
0.000.00%
Last trade - 00:00
- £0.87m
- £36.05m
- $31.55m
- 15
- 85
- 13
- 27
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 6.08 | -93.6 | -10.3 | 5.7 | -12.2 |
Depreciation | |||||
Non-Cash Items | 1.01 | 92.9 | 2.01 | -10.4 | 9.92 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.333 | 11.8 | 2.51 | 4.45 | 5.07 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 14.7 | 21.7 | 4.54 | 11.2 | 11.6 |
Capital Expenditures | -8.42 | -12.9 | -11.6 | -21.1 | -21.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -15 | -2.63 | -0.509 | 3.74 | 1.59 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -23.5 | -15.5 | -12.1 | -17.3 | -20.2 |
Financing Cash Flow Items | -2.71 | -4.04 | -0.696 | -1.34 | -4.37 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6.75 | -6.68 | 3.53 | 6.43 | 13.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.06 | -1.07 | 0.249 | 0.87 | 5.93 |